CrushSCI.com
Journal Selection & Manuscript Polishing Services
Therapeutic Innovation & Regulatory Science journal cover Medicine
Back to journal directory

Review Cycle Records

Therapeutic Innovation & Regulatory Science

Springer SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 42025 JCR Q3
167.7Average days
158Median days
44Fastest days
303Longest days
1682025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

270 days

Therapeutic Horizon in Multiple Myeloma: Analysis of the Emerging Landscape of Clinical Trials

AuthorsMarina Alacoque Rodrigues; Cristiane Aparecida Menezes de Pádua; Paula Lana de Miranda Drummond; Jéssica Soares Malta; Adriano Max Moreira Reis

Affiliations1. College of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; 2. Fundação Ezequiel Dias, Belo Horizonte, Brazil

Source PDF DOI Publisher page
130 days

Advancing Wider Implementation of Multi-regional Clinical Trials in East Asia

AuthorsJohn H. Skerritt; Irene Chan; Aloka Chakravarty

Affiliations1. Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia; 2. Eli Lilly and Co, Indianapolis, USA

Source PDF DOI Publisher page
140 days

Pharmacovigilance Data From Digital Health Systems: Regulations, Implications, and Opportunities—A TransCelerate Perspective

AuthorsJames Whitehead; Rajesh Ghosh; Anna Monaco; Jackie Grissinger; Inessa Neyman; Tom Umrath; Clint Craun

Affiliations1. AstraZeneca, Newmarket, England, UK; 2. Genentech/Hoffman LaRoche Ltd., South San Francisco, USA; 3. Merck & Co., Inc., Rahway, USA; 4. Johnson & Johnson, New Brunswick, USA; 5. Pfizer Global Pharmaceuticals, New York, USA; 6. Novartis Pharmaceuticals Corporation, East Hanover, USA; 7. TransCelerate BioPharma Inc., West Conshohocken, USA

Source PDF DOI Publisher page
74 days

Analyses of U.S. FDA GCP Assessments and Recommendations for Marketing Applications, 2015–2024

AuthorsCourtney McGuire; Michelle Foringer; David Burrow; Jenn Sellers; Cheryl Grandinetti; Kassa Ayalew

Affiliations1. Office of Scientific Investigations (OSI), Office of Compliance (OC), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, USA

Source PDF DOI Publisher page
164 days

Comparative Assessment of the Pharmaceutical Quality of Amoxicillin Capsules Marketed in Authorized and an Unregulated Point of Sale in Mexican Market

AuthorsGael Marmolejo-Bernal; Leny Mejía-Amaro; Teresa Benítez-Escamilla; Alberta Lourdes Castillo-Granada; Leticia Cruz-Antonio

Affiliations1. Facultad de Estudios Superiores Zaragoza, UNAM, Ciudad de México, Mexico

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.